Experts say the approach could also save millions of pounds by cutting projects or clinical trials that would otherwise fail.
Improved patient outcomes, streamlined medical research, and better optimised workflows for healthcare professionals are just ...
Scientists have developed a revolutionary AI "fingerprint" technology that can accurately show how cancer cells respond to ...
Pathology is a field that seems ripe for assistance from recent advances in artificial intelligence. Beck’s company is one of ...
Another company involved in using AI to repurpose failed drugs – as well as drugs that have already been approved – is ...
Artificial intelligence continues stirring things up in chemistry. To wit: Y Combinator-backed Cambridge, U.K.-based ...
During a health-focused event in New York on Tuesday, Google announced that it's developing a collection of "open" AI models ...
Artificial Intelligence is revolutionizing pharmaceuticals, accelerating drug discovery, and optimizing clinical trials. Yet, ...
RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.
Insilico Medicine, whose Hong Kong IPO application lapsed in 2024, is still considering going public in the city, said ...
A little over a year ago, a Renton man was told there was only one thing left to decide. Did he want to die at home, or in ...
Charles River and Valo Health announce the identification of an advanceable product candidate for treatment of lupus and other autoimmune diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results